ESMO Gastrointestinal Oncology Gastroenterology
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies
The publisher did not provide an abstract — full text is available via the link below.